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and methionine-enkephalin in human dental pulp tissue after
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ABSTRACT
Objective: To determine the levels of two sensory neuropeptides (substance P [SP] and calcitonin
gene-related peptide [CGRP]) and two endogenous opioids (methionine-enkephalin [Met-Enk] and b-
endorphin [b-End]) in dental pulp tissue samples subjected to controlled orthodontic intrusive forces.
Materials and Methods: Sixteen healthy premolars were selected from eight patients who were
undergoing extraction for orthodontic purposes. Eight were randomly used as controls, and the
other eight were assigned to an experimental group (controlled orthodontic intrusive forces applied
for 24 hours). After this period, teeth were extracted, and pulp samples were obtained. All samples
were processed to quantify the expression levels of SP, CGRP, Met-Enk, and b-End using
commercial radioimmunoassay kits.
Results: All samples exhibited basal levels of both neuropeptides and endogenous opioids. After
24 hours of the intrusive stimulus, all patients reported a tolerable discomfort localized at the
involved premolar. Only SP was significantly increased (P , .05). For the other molecules, no
statistically significant differences were observed (P . .05); however, they expressed important
increasing trends.
Conclusions: The expression levels of SP and CGRP in dental pulp samples from the
experimental group support the positive correlation between the symptomatic clinical scenario and
increased expression levels of neuropeptides, clarifying the role of neurogenic inflammation in
early injury response. (Angle Orthod. 2014;84:521–526.)
KEY WORDS: Neurogenic inflammation; Endogenous opioid system; Substance P; Calcitonin
gene-related peptide; Methionine-enkephalin; b-endorphin
INTRODUCTION
Orthodontic forces are capable of producing neuro-
vascular changes within dental pulp tissue, partially
mediated by the local release of neuropeptides.1,2 Not
only do these influence vascular and nervous struc-
tures, but they can also target immune cells.3
Substance P (SP) is considered to be the main
mediator of neurogenic inflammation.4 It presents a
dose-dependent effect and causes vasodilatation by
direct action over endothelial cells and indirect mast-
cell stimulation for histamine release, a dual effect
shared with calcitonin gene-related peptide (CGRP).5,6
CGRP is recognized as the most potent vasodilatory
peptide7 and is found in nearly 50% of the neurons of
the trigeminal system.6 Frequently collocated and
released with SP,8 it is capable of extending this
neuropeptide activity by inhibiting enzyme degrada-
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tion.9 Both are well-known key factors related to painful
clinical scenarios.3,8
Pain perception also activates pain-inhibition sys-
tems.10 The most relevant analgesic mechanism is the
opioid endogenous system, which was identified in the
late 1980s in both central and peripheral sensory
neurons.11 This system consists of different opioid
peptides, for instance, b-endorphin (b-End) and
methionine-enkephalin (Met-Enk).12,13 Met-Enk and b-
End are capable of stimulating m and d opioid receptors
and d opioid receptors, respectively, causing direct
analgesia14,15 by attenuation of neuronal excitability
and neuropeptidergic release.16
Until now, only a few reports have explored the
relationship between the development of neurogenic
inflammation caused by neuropeptides and the local
pain modulation mechanisms mediated by the pres-
ence of endogenous opioids in the dental pulp
environment. The aim of this study was to determine
the levels of two sensory neuropeptides (SP and
CGRP) and two endogenous opioids (Met-Enk and b-
End) in dental pulp tissue samples subjected to
controlled orthodontic intrusive forces.
MATERIALS AND METHODS
Subjects
A descriptive comparative pilot study was conducted
in accordance with the Declaration of Helsinki. The
Ethics Committee of the Faculty of Dentistry at San Luis
Potosi University, San Luis Potosi, Mexico approved
this study, whose objective was explained to the
subjects’ parents or legal guardians and for which
written informed consent was obtained. Study subjects
were eight patients of both sexes between 12 and
16 years old. The inclusion criteria were systemically
healthy; undergoing extraction of the four first premolars
for orthodontic purposes; teeth without caries, fractures,
or periodontal disease tested to establish pulpal/
periradicular health and with radiographically evident
complete radicular formation. Patients who received
recent anti-inflammatory, analgesic, or antibiotic treat-
ment; who had root resorption (from any cause),
permanent or provisional restorations in the first
premolars, or radicular dilacerations; who were smok-
ers; who were pregnant; or who had occlusal disorders
were excluded. Each patient was assigned sequential
numbers in the order in which they were enrolled, and
they received their allocated treatment according to a
computer-generated randomization schedule.
Experimental Design
Initially, a pilot study was performed to design in vitro
the intrusive device to be used. Standard 0.0180
orthodontic brackets and double tubes (Sybron/
Ormco, Orange, Calif) were selected for the first
premolars and the permanent first molars, respec-
tively. Both brackets were placed in plastic dento-
forms using the adhesive system Prime & Bond (3M
Unitek, Monrovia, Calif) and composite Filtek 350
(3M Unitek), standardizing their positions with an
Anderson calibrator (Dentaurum GmbH, Ispringen,
Germany). Using No.139 orthodontic pliers (Den-
taurum GmbH), a 1-mm loop was formed with a
retentive fold on the opposite side of a stainless steel
wire (0.0180 3 0.0250). The customized wire was
placed in the tube slot and adjusted to allow the loop
to be bent until an acute angle was achieved. Using a
dynamometer (Corex, Haag-Streit, Kowniz, Switzer-
land), the angulation was standardized at 40u to
allow for a 150–200 g intrusive force over the plastic
tooth.
Two premolars from each patient were randomly
selected and assigned to two different groups: the
experimental group, which would undergo the appli-
cation of the controlled intrusive force for 24 hours
(EXPg), and the control group (CTRg), which was
used to determine the basal levels of each sub-
stance. Each patient was scheduled so as to obtain
the samples from the control tooth before any clinical
intervention took place. Each control tooth was
anesthetized via local blockage with 4% prilocaine
(Pricanest, Ropsohn Therapeutics, Bogota´, Colom-
bia). From that moment, the entire sampling proce-
dure was performed within a 10-minute period. After
extraction, a second assistant created a 1-mm
longitudinal groove over the vestibular tooth surface
using a high-speed diamond bur with copious
irrigation to facilitate the mechanical fracture of the
tooth and the acquisition of pulpal tissue, which was
immediately stored in a tagged cryovial containing
1.8 mL of 4% paraformaldehyde, according to
previous studies.17 The cryovial was transported
and stored at 270uC. The orthodontic device as-
signed to the EXPg was then placed on the first
premolar. After its activation, each patient was
instructed to call if any problem or severe discomfort
was experienced and, if necessary, to take 400 mg of
ibuprofen as a rescue analgesic. These patients were
excluded. Pain was scored using a Heft-Parker visual
analog scale (VAS) based on a 170-mm line
determining the pain level; accordingly, no pain
corresponded with 0 mm, mild pain with 1 to 54 mm,
moderate pain with 55 to 113 mm, and severe pain as
greater than 113 mm.
After 24 hours of controlled intrusive force applica-
tion, the patient was asked to return to the university
facilities, where the dental pulp from the experimental
tooth was obtained as described earlier.
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Radioimmunoassay
A radioimmunoassay (RIA) was performed to
quantify the amount of each substance obtained from
each sample. SP, CGRP, b-End, and Met-Enk release
were determined by competition RIA binding assays
using a human SP RIA kit (reference RK-061-05), a
human CGRP RIA kit (reference RK-015-02), a human
b-End RIA kit (reference RK-022-14) (Phoenix Peptide
Pharmaceuticals, Burlingame, Calif), and a human
Met-Enk RIA kit (reference S-2119) (Peninsula Labo-
ratories LLC, Bachem Group, San Carlos, Calif). For
each kit, 100 mL of antiserum and 100 mL of various
neuropeptide/opioid concentrations (1–128 pg mL-1) or
100 mL of dental pulp tissue extracts were incubated in
polypropylene tubes at room temperature for 20 hours.
Then, 100 mL of radioactive 125I tracer was added and
left to incubate for another 24 hours. Bound fractions
were precipitated by the addition of 100 mL of a
secondary antibody (goat anti-rabbit immunoglobulin
G serum), 100 mL normal rabbit serum, and 500 mL
RIA buffer containing 1% polyethylene glycol 4000.
After 2 hours of incubation at room temperature, the
suspensions were spun at 3,500 rpm (4,000 g) for
40 minutes at 4uC to precipitate the bound fractions.
The supernatants were carefully aspirated, and pellet
radioactivity was read on a gamma counter (Model
B5002, Packard Instrument Intl, Zurich, Switzerland).
All samples were assayed in duplicate, and the mean
values were calculated. Finally, Scatchard analysis of
the binding data was used to assess the amount of
neuropeptide/opioid present in each sample.
Statistical Analysis
Results were analyzed by the Mann-Whitney U test
to compare the differences among groups for contin-
uous variables. A difference was considered to be
significant if the probability of its occurring by chance
alone was ,5% (P , .05) in a two-tailed test.
RESULTS
The results are shown in Figure 1. All samples from
the CTRg exhibited basal levels of neuropeptides and
endogenous opioids. A higher basal level was ob-
served for SP, measuring 83.51 pg/mg of dental pulp
tissue (611.35 pg), followed by CGRP (13.73 6
2.84 pg/mg), b-End (12.44 6 1.74 pg/mg), and finally
Met-Enk (2.29 6 0.84 pg/mg), the least-expressed
molecule at basal levels. In the EXPg, after 24 hours of
the intrusive stimulus, none of the patients needed to
use the rescue analgesic for severe pain, but they all
reported a tolerable discomfort localized at the
involved premolar. After orthodontic intrusion, SP
was the only substance that exhibited statistically
significantly different levels in dental pulp samples, in
which a level of 131.91 (626.32 pg) was measured
Figure 1. Basal and experimental levels for both neuropeptides and endogenous opioids. *P , .05. Data are presented in picograms of each
substance per milligram of dental pulp sample; CTRg indicates control group; EXPg, experimental group; SP, substance P; CGRP, calcitonin
gene-related peptide; b-END, b-endorphin; MET-ENK, methionine-enkephalin.
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(P , .05). Although none of the other samples showed
statistically significant differences for the other mole-
cules (P . 0.05), they all expressed important
increasing trends in the EXPg: 16.03 (62.74 pg),
15.64 (62.33 pg), and 15.02 (6 9.14 pg) for CGRP,
b-End, and Met-Enk, respectively.
DISCUSSION
This pilot study simultaneously determined the
expression levels of two proalgesic neuropeptides
and two analgesic endogenous opioid peptides during
an induced acute inflammation environment in eight
healthy human patients. No previous reports have
analyzed both types of substances in dental pulp at the
same time.
An orthodontic movement methodology was select-
ed as a well-standardized available model for human
clinical trials focused on inflammation.18 The amount of
intrusive force needed for each premolar assigned to
the EXPg was considered. Different reports have used
a large variety of forces, ranging from 35 g to 600 g.19–21
In this study, it was decided to implement 150–250 g of
intrusive force. Even now, defining an orthodontic force
as normal remains a paradigm.22 The use of intrusive
forces avoids the creation of new interferences that may
be seen with a different kind of movement, which
ultimately will increase the bias or pain incidence in the
study.
All basal levels for neuropeptides and endogenous
opioids were determined. The presence of these two
substances in dental pulp tissue concurs with the
findings of previous reports.5,19,23–25 Although the origin
of sensory neuropeptides lies in the trigeminal central
tissue, optimal axonal transportation allows for such
local storage in nerve terminals.26 For endogenous
opioids, the local source is mainly located in different
cellular populations, such as immunocytes.11
After the activation of orthodontic intrusive devices,
patients reported a tolerable discomfort. Within the
molecules capable of provoking this response, SP and
CGRP are well recognized. Nevertheless, none of the
subjects required analgesics or reported a degree of
pain that caused elimination from the study.
The SP levels increased by 57.97%; this was a
significant difference from the basal levels (P , .05).
The increase of SP coincided with reports of a higher
expression in symptomatic cases of irreversible
pulpitis17,21,26 and cases in which inflammation was
induced, such as deep restorative cavities, the use of
certain whitening systems, and the placement of
adhesives for cervical preparations.27 Specifically, a
greater immunoreactive presence of SP on cats’ teeth
was reported when orthodontic movement was ap-
plied.28 CGRP expression levels were also higher but
were not significantly different (P . 0.05). Such an
increase was noted when irreversible pulpitis was
diagnosed17,26 after 10 minutes of induced pulp
inflammation27 and after orthodontic stimulation.29
When considered together, it must be remembered
that both are known to be collocated within the same
sensory nonmyelinated fiber, a fact corroborated by
evidence that demonstrated that an increased density
of both nerve-containing fibers is found in the dental
pulp of mechanically stressed teeth.30 The presence of
these two factors in pulp tissue may not be surprising,
as 87% of the axons that enter through the apical
region of a premolar are C nonmyelinated fibres.31 Our
results and current evidence support the finding that
orthodontic movement is not limited to the periodontal
tissue but also involves biochemical and symptomatic
changes that may affect the dental pulp.
None of the endogenous opioids exhibited statisti-
cally significant differences compared with control
levels; however, a considerable increase was appre-
ciable for both. Even peripheral opioid mechanisms
are more evident in the function of the duration and
severity of the stimulus,11 but for ethical reasons, our
model intensity could not provoke any harm in healthy
human patients. Opioid increase results from the
recruitment of immune cells to the damaged tissue13
after the influence of chemokines that favor its
migration. Orthodontic stimulus causes cellular che-
motaxis, which is different in the function of elapsed
time. Granulocytes are the main population of cells
observed during the first day of movement,32 and this
cell type is also known as the major source of opioid
peptide production.33 Other studies have confirmed an
increase of granulocytes that are positively marked for
b-End after 6 hours of induced inflammation.34 In
specific patients with lower pain thresholds due to
inflammation, the increase of b-End may not be
sufficient to suppress pain in which the balance
between analgesia and sensitization is shifted toward
pain experience,10 a similar behavior as that observed
in our study.
Controversy surrounds the data obtained for Met-
Enk, in which, contrary to our results, a decrease of
this opioid has been reported in dental pulp after
orthodontic exposure.19 Another study35 analyzed the
dental pulp expression levels for SP and Met-Enk, also
reporting different results from those obtained in this
work. In this case, variables such as the anesthetic
solution and the sampling sequence used may explain
why control levels are even higher than experimental
ones. Until now, the previous two reports have been
the only attempts to study the simultaneous behavior
of neurogenic inflammation and endogenous opioid
systems during acute inflammation due to orthodontic
movement in human teeth.
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Available evidence offers an interesting theoretical
paradox. Neuropeptides capable of causing pain favor
the recruitment of some of the leukocytes responsible
for releasing the endogenous opioids;36 thus, neuro-
genic painful responses may also indirectly activate
peripheral pain modulation mechanisms, attenuating
its severity. Additionally, the presence of opioids can
inhibit the sensory neurons’ excitability and thus the
neuropeptide release. Accordingly, each substance
may not exert individual effects but rather may produce
cross-control mechanisms, especially as the source of
both neuropeptides also expresses m opioid and d
opioid receptors for Met-Enk and b-End.16,37 This
hypothetical correlation and its relevance must be
evaluated in further research. Also, further studies with
more patients are needed to confirm these findings.
CONCLUSIONS
N SP and CGRP levels in dental pulp samples from the
EXPg support the positive correlation between the
symptomatic clinical scenario and increased expres-
sion levels of neuropeptides, clarifying the role of
neurogenic inflammation in the early injury response.
N In the same environment, the low increasing ten-
dency observed in the endogenous opioid levels
illustrates a poorly established pain-modulating
system during the first 24 hours of orthodontic
intrusion.
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